Improving Precision & Safety in Gene Therapy Through Engineered AAV Capsids

3:45 pm - Thursday 26th March 2026

  • Investigating how engineered capsids increase efficiency and safety
  • Evaluating design strategies that help avoid immune responses to repeat dosing
  • Understanding how capsid can enable gene therapy for muscle, brain, and other organs

Speakers:

Senior Director - Chemistry, Manufacturing & Controls
Apertura Gene Therapy